ISIS Pharma Called A 'Sleeper Awakening' At Piper Jaffray By: Benzinga via Benzinga November 05, 2015 at 10:25 AM EST ISIS Pharmaceuticals, Inc. (NASDAQ: ISIS) shares are down 12 percent year-to-date, after hitting a high of $77.08 on March ... Read More >> Related Stocks: Alnylam Pharmaceuticals Amgen Biogen Idec Gilead Sciences Gsk Plc ADR Sanofi-Aventis S.A. ADR